Haruko Shimoda

773 total citations
16 papers, 350 citations indexed

About

Haruko Shimoda is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Haruko Shimoda has authored 16 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Haruko Shimoda's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Haruko Shimoda is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Eosinophilic Disorders and Syndromes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Haruko Shimoda collaborates with scholars based in Japan. Haruko Shimoda's co-authors include Kazuya Shimoda, Kotaro Shide, Takuro Kameda, Yoko Kubuki, Kenji Nagata, Tadashi Matsuda, Satoru Hasuike, Tomonori Hidaka, Yoshihiro Tahara and K Takenaka and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and British Journal of Haematology.

In The Last Decade

Haruko Shimoda

16 papers receiving 341 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Haruko Shimoda	232	207	201	80	58	16	350
Ayako Kamiunten	60 0.3×	90 0.4×	89 0.4×	16 0.2×	32 0.6×	21	188
P. Martiat	192 0.8×	145 0.7×	258 1.3×	48 0.6×	45 0.8×	16	394
D. Oscier	163 0.7×	92 0.4×	90 0.4×	17 0.2×	50 0.9×	17	282
Bárbara da Costa Reis Monte-Mór	144 0.6×	267 1.3×	172 0.9×	33 0.4×	49 0.8×	19	367
Fiona Watkins	117 0.5×	180 0.9×	246 1.2×	18 0.2×	38 0.7×	8	379
Inmaculada Rapado	112 0.5×	238 1.1×	163 0.8×	40 0.5×	64 1.1×	30	370
Jutta Proba	67 0.3×	161 0.8×	127 0.6×	29 0.4×	139 2.4×	6	341
L C Chan	101 0.4×	221 1.1×	194 1.0×	20 0.3×	32 0.6×	10	399
Rebecca Austin	118 0.5×	135 0.7×	180 0.9×	50 0.6×	48 0.8×	6	297
AP Guo	226 1.0×	34 0.2×	371 1.8×	78 1.0×	46 0.8×	8	403

Countries citing papers authored by Haruko Shimoda

Since Specialization

Citations

This map shows the geographic impact of Haruko Shimoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruko Shimoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruko Shimoda more than expected).

Fields of papers citing papers by Haruko Shimoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruko Shimoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruko Shimoda. The network helps show where Haruko Shimoda may publish in the future.

Co-authorship network of co-authors of Haruko Shimoda

This figure shows the co-authorship network connecting the top 25 collaborators of Haruko Shimoda. A scholar is included among the top collaborators of Haruko Shimoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruko Shimoda. Haruko Shimoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Akizuki, Keiichi, Hitoshi Matsuoka, Ayako Kamiunten, et al.. (2020). Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan. Journal of Clinical Medicine. 10(1). 105–105. 9 indexed citations

Kamiunten, Ayako, Masaaki Sekine, Takuro Kameda, et al.. (2018). Outcome of allogeneic hematopoietic cell transplantation in patients with adult T‐cell leukemia. Hematological Oncology. 36(4). 651–655. 4 indexed citations

Shide, Kotaro, Takuro Kameda, Masaaki Sekine, et al.. (2017). Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2V617F-induced Murine Myeloproliferative Neoplasm. Anticancer Research. 37(7). 3841–3847. 1 indexed citations

Sekine, Masaaki, Yoko Kubuki, Takuro Kameda, et al.. (2017). Effects of mogamulizumab in adult T‐cell leukemia/lymphoma in clinical practice. European Journal Of Haematology. 98(5). 501–507. 17 indexed citations

Shimoda, Kazuya, Kotaro Shide, Takuro Kameda, et al.. (2015). TET2 Mutation in Adult T-Cell Leukemia/Lymphoma. Journal of Clinical and Experimental Hematopathology. 55(3). 145–149. 16 indexed citations

Shide, Kotaro, Takuro Kameda, Ayako Kamiunten, et al.. (2014). Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F. Blood. 124(21). 162–162. 1 indexed citations

Shide, Kotaro, Takuro Kameda, Haruko Shimoda, et al.. (2012). TET2 is essential for survival and hematopoietic stem cell homeostasis. Leukemia. 26(10). 2216–2223. 64 indexed citations

Takenaka, Katsuto, Takuro Kuriyama, Kotaro Shide, et al.. (2010). JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation. British Journal of Haematology. 150(3). 334–344. 43 indexed citations

Kameda, Takuro, Kotaro Shide, Haruko Shimoda, et al.. (2010). Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma. International Journal of Hematology. 92(2). 320–325. 10 indexed citations

10.

Shimoda, Haruko, Kotaro Shide, Takuro Kameda, Takuya Matsunaga, & Kazuya Shimoda. (2010). Tyrosine kinase 2 interacts with the proapoptotic protein Siva-1 and augments its apoptotic functions. Biochemical and Biophysical Research Communications. 400(2). 252–257. 10 indexed citations

11.

Shide, Kotaro, Yohei Nakaya, Takuro Kameda, et al.. (2010). NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant. Blood. 116(21). 4106–4106. 7 indexed citations

12.

Taniguchi, Yasuhiro, Tomonori Hidaka, Takuro Kameda, et al.. (2010). [Antiphospholipid syndrome with autoimmune hemolytic anemia which mimics thrombotic thrombocytopenic purpura].. PubMed. 51(4). 275–80. 3 indexed citations

13.

Hidaka, Tomonori, Kotaro Shide, Haruko Shimoda, et al.. (2009). The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan. European Journal Of Haematology. 83(4). 328–333. 18 indexed citations

14.

Shide, Kotaro, Takuro Kameda, Vadim Markovtsov, et al.. (2009). Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2V617F-Induced Murine MPD Model.. Blood. 114(22). 3897–3897. 9 indexed citations

15.

Shimoda, Haruko, Masahiro Yamamoto, Kotaro Shide, et al.. (2007). Chronic thrombopoietin overexpression induces mesangioproliferative glomerulopathy in mice. American Journal of Hematology. 82(9). 802–806. 5 indexed citations

16.

Shide, Kotaro, Haruko Shimoda, Kennosuke Karube, et al.. (2007). Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F. Leukemia. 22(1). 87–95. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact